Carmell Corp - XAGE Enterprise Value to EBITDA Ratio
The current market quotes for Longevity Health Holdings (XAGE) visualized below, with an EV/EBITDA of , supplement data on a company with moderate macroeconomic resilience and a demand for aesthetic medicine that is moderately dependent on consumer income. The business minimizes risks by developing bioactive components for tissue regeneration in orthopedics. Sales of premium biotechnological products are currently scaling rapidly through specialized clinics.
carmellcosmetics.com - analytical breakdowns and key metrics (XAGE)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity Longevity Health Holdings|XAGE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Carmell Therapeutics|XAGE - Company Total Indebtedness|Debts to Book Capitalization Carmell Corp|XAGE - Long-Term Debt|Company Current Liabilities Longevity Health Holdings|Quick Ratio carmellcosmetics.com
- business earnings and investment ratios data:
XAGE - Net Financial Result|Future Profit Longevity Health Holdings|XAGE - Market Price to Net Income Ratio|Projected Price to Earnings Longevity Health Holdings|XAGE - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Carmell Corp|XAGE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Longevity Health Holdings|XAGE - Earnings per share for the trailing year|Quarterly EPS earnings growth carmellcosmetics.com|XAGE - Earnings per share growth rate in current year|Earnings growth forecast for next year Longevity Health Holdings
Basic company analysis:Longevity Health Holdings Inc XAGE
This indicator determines the investment reliability of the issuer by comparing the total enterprise value, accounting for net debt and taxes, to its operating profit. Analyzing the current EV/EBITDA ratio with debt allows for the elimination of accounting distortions to assess the real value of assets. For Longevity Health Holdings (XAGE), such a metric confirms the stability of a capital-intensive pharmaceutical logistics infrastructure that ensures the integrity of medications during transport.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|UHS (Universal Health Services, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|Company Value to EBITDA RadNet Management RDNT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Health (OPCH)|surgerypartners.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple PINC (Premier)|Enterprise Value to EBITDA Multiple National Vision Holdings, Inc.|Progyny Health - EV/EBITDA Multiple|Company Value to EBITDA Ardent Health Corp|SEM (Select Medical) - Enterprise Value to EBITDA Ratio|ASTH (astranahealth.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MD (Pediatrix) - EV/EBITDA Multiple|US Physical Therapy Inc (USPH) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PNTG (Pennant Group Inc)|Enterprise Value to Operating Income Before Depreciation Ratio ORGO|Nutex Health Inc. - Enterprise Value to EBITDA Ratio|aunainvestors.com (AUNA) - Company Value to EBITDA|SBC: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation EOLS (Evolus Inc)|CYH: EV/EBITDA Multiple|BeautyHealth - Business Value to Operating Income Before Depreciation|MDWD (MediWound Ltd) - EV/EBITDA Multiple|Company Value to EBITDA biote.com BTMD|EV/EBITDA Multiple JYNT|EV/EBITDA Multiple DocGo, Inc. (DCGO)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization P3 Health Partners PIII|gaintherapeutics.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EUDA: Enterprise Value to EBITDA Ratio|Basel Medical Group - Enterprise Value to Operating Income Before Depreciation Ratio|CLGN: EV/EBITDA Multiple|Cuprina Holdings (Cayman) Ltd. - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio CCM|AMS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple MRM|ALBT (avalon-globocare.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DIH Holding DHAI|NewGenIvf Group (NIVF) - Company Value to EBITDA|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CMAX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KDLY: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation MODV|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|SunLink Health Systems, Inc (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IMAC Regeneration Centers (BACK)
